Head-to-head · WeighScore
FuturHealth vs Nalena
The verdict
Nalena takes it — 71.2/100 to 65.6/100.
Nalena grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Nalena is a women-focused, GLP-1-only telehealth platform offering compounded semaglutide and tirzepatide with medication included — no separate membership or visit fees.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | FuturHealth | Nalena |
|---|---|---|
| WeighScore | 65.6/100 | 71.2/100 |
| Grade | C | C |
| Scorecard rank | #219 | #98 |
| Semaglutide | $199/mo (compounded) | $149/mo (starting dose, compounded) |
| Tirzepatide | Not disclosed | $149/mo (starting dose, compounded) |
| Coverage | Coverage not published | All 50 states |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Yes | Injection only |
Graded #219 · C
Strengths
- LegitScript Certified and HITRUST Certified
- Brand-name and oral GLP-1s on one platform: Wegovy injection and pill, Zepbound, Mounjaro, Ozempic, and Foundayo
- Early direct-to-consumer access to Foundayo (orforglipron), the new oral non-peptide GLP-1
- Bundled registered-dietitian nutrition guidance — uncommon among pure-Rx telehealths
Where it loses points
- Active lawsuit (Wilson v. FuturHealth) alleging unauthorized access to G-Plans subscriber data
- BBB complaints describe recurring charges without medication received — confirm cancellation flow first
- Pharmacy partners described only as 'licensed, U.S.-based' with no specific 503A/503B names
- Pricing not shown until after the qualification questionnaire or portal login
- Front-end brand built on SteadyMD and OpenLoop infrastructure, not a first-party prescriber
Graded #98 · C
Strengths
- Compounded GLP-1 from $149/mo with medication included — near the floor of the compounded market
- Transparent fee model: no hidden fees, no membership, cancel anytime
- Money-back guarantee — uncommon among compounded telehealths
- Clinical provider disclosed: Beluga Health, P.A. in Houston, TX
- Women-focused positioning
Where it loses points
- Per-dose pricing not published — only the 'starting at $149' entry price
- No LegitScript, HIPAA, or NABP badges on public pages
- Compounding pharmacy partners not named (only 'multiple USA certified pharmacies')
- Houston address looks like a virtual office rather than a clinical facility
- No brand-name GLP-1s (Wegovy, Zepbound, Ozempic, Mounjaro) — compounded only
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.